Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126264821 | 12626482 | 1 | I | 20160724 | 20160805 | 20160805 | EXP | US-SA-2016SA138062 | AVENTIS | O^SULLIVAN KL, ZEYTINOGLU M, VOKES TJ. SEVERE HYPERCALCEMIA EXACERBATED BY EXCESSIVE VITAMIN D SUPPLEMENTATION IN THE SETTING OF PRIMARY HYPERPARATHYROIDISM. 96TH ANNUAL MEETING AND EXPO OF THE ENDOCRINE SOCIETY, ENDO 2014; 2014 JUN 21-24; CHICAGO, IL, UNITED STATES. ENDOCR REV. 2014 JAN;35 SUPPL 3 | 73.00 | YR | E | F | Y | 0.00000 | 20160805 | OT | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126264821 | 12626482 | 1 | PS | ERGOCALCIFEROL. | ERGOCALCIFEROL | 1 | Unknown | DOSE:5000 UNIT(S) | U | UNK | 999999 | /wk | |||||||
| 126264821 | 12626482 | 2 | SS | CHOLECALCIFEROL | CHOLECALCIFEROL | 1 | Unknown | DOSE:5000 UNIT(S) | U | UNK | 0 | QD |
Indications of drugs used
| no results found |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126264821 | 12626482 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126264821 | 12626482 | Hypercalcaemia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |